Sell-Side Consensus

Consensus as at 01/05/2021

  FY2021
CONTINUING OPERATIONS  
Underlying revenue growth (%)  
John Crane (6)
Smiths Detection (5) 
Flex-Tek
Smiths Interconnect
Continuing Operations (3) 
 
Revenue (£m)  
John Crane 856 
Smiths Detection 739 
Flex-Tek 484 
Smiths Interconnect 317 
Continuing Operations 2,395 
 
Operating profit (£m)  
Continuing Operations 357 
 
DISCONTINUED OPERATIONS (Smiths Medical)  
Underlying revenue growth (%)
Revenue (£m) 883 
Operating profit (£m) 188 

Continuing Operations excludes Smiths Medical which is accounted for as 'discontinued operations - businesses held for distribution to owners'.

Accounting standards require the Group to stop charging depreciation and amortisation within Smiths Medical, since it has been reclassified as discontinued operations. Therefore, Smiths Medical's FY operating profit includes an estimated £45m credit for depreciation and amortisation and analysts' forecasts have been manually adjusted to reflect this if required.

Consensus is comprised of 10 analyst forecasts: JP Morgan, Goldman Sachs, BofA, Barclays, Credit Suisse, Exane BNPP, Investec, Morgan Stanley, RBC, Stifel